Mediport gets behind active cold chain network

Mediport's refrigerated van fleet.

A transformative shift in medical logistics is gathering momentum ahead of the 2025 national packaging target.

Active Cold Chain Network, a movement within the industry, has been spurred by the need to reduce environmental impacts and ensure safer transportation of critical medications.

As a result local businesses have the opportunity to drastically reduce costs in the pharmaceutical supply sector.

National cold chain carrier, Mediport, is one such business that is seeing the economic and environmental benefits delivered by embracing more sustainable cold chain solutions.

The broader industry’s commitment to sustainable practices and the Active Cold Chain Network, is not just a singular solution but emblematic of a collective effort to address the polystyrene predicament according to Mediport CEO Marcus Lethlean.

“Active Cold Chain Networks represent an innovative paradigm in medical logistics, reconciling the demands of sustainability with the imperative to safeguard vital medications during transport,” he said.

“It’s a pivotal moment where the entire industry can champion both healthcare and environmental responsibility.”

A wider adoption of active refrigeration within the Cold Chain Network can offer a scalable model for pharmaceutical supply chains across the country.

Refrigerated vans and light-duty trucks are anticipated to result in lighter shipments, leading to reduced fuel consumption while the integration of recycled packaging materials and a streamlined delivery process should lead to greater efficiency.

Mediport maintains a specialty fleet of 50 vans that offers a temperature sensitive portable coolroom and delivers Australia-wide.

“Active refrigeration is not just a technological leap — it’s a strategic move towards sustainability,” said Lethlean.

“The weight reduction, cardboard recycling, and enhanced delivery efficiency showcase the power of innovation in mitigating our environmental impact collectively.”

As the industry collectively approaches the 2025 national packaging targets, solutions like the Active Cold Chain Network has emerged as a proven alternative to traditional polystyrene packing, offering a viable and scalable approach within the industry’s limited timeframe.

“While individual companies like Mediport are making significant strides, the urgency for an industry-wide shift towards sustainable practices is clear,” said Lethlean.

“Active Cold Chain Networks are not just solutions, they represent a shared commitment to fostering a greener future for medical logistics.”

Mediport recently launched its services into Tasmania.

The ‘active transport’ solution not only cuts polystyrene plastics but has been found, according to a recent DHL report, to reduce carbon emissions by over a third.

Even though specialist packaging, including medical polystyrene, wasn’t highlighted as a priority in the government’s roadmap to phasing out EPS packaging, businesses across the industry are actively exploring new options.

Mediport CEO Marcus Lethlean.
Marcus Lethlean.
Send this to a friend